Biotech pioneer seals £1.1m funding boost

NEWCASTLE biotech business has secured a milestone £1.1m funding boost to ramp up its pioneering work.

- COREENA FORD

Nanovery has been developing nanorobots to help detect deadly diseases such as cancer since its launch in 2018. Co-founders Dr Jurek Kozyra and Roma Galloway wanted to launch a more efficient diagnostics solution for serious diseases, to bring more regular testing to clinicians and patients.

The firm's platform of analytical tools are used in the development of a new class of drugs known as RNA therapeutics a market potentially worth $20bn by 2030 which are opening the door to addressing previously untreatable diseases, including several cancers. RNA therapies offer advantages including the ability to design and develop new drugs more quickly than conventional methods.

However, the stability of RNA molecules and the ability to deliver them to their intended site are among current challenges in the treatment.